Suppr超能文献

严重急性呼吸综合征冠状病毒2感染:全球大流行及其对公共卫生的影响

SARS-CoV-2 infection: a global outbreak and its implication on public health.

作者信息

Mohan Sankari, Anjum M Reshma, Kodidasu Anusha, Prathyusha T V N Sai, Mrunalini Nunna Venkata, Kishori B

机构信息

Sri Padmavathi Mahila Visvavidyalayam (Women's University), Tirupati, Andhra Pradesh India.

出版信息

Bull Natl Res Cent. 2021;45(1):139. doi: 10.1186/s42269-021-00599-7. Epub 2021 Aug 3.

Abstract

BACKGROUND

A novel corona virus is formally named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which results in causing coronavirus disease 2019 (COVID-19). It is the latest prevalent pandemic worldwide when compared to other infectious diseases like Avian flu, Middle East respiratory syndrome and severe acute respiratory syndrome (SARS).

MAIN BODY

Coronavirus disease 2019 (COVID-19) is currently occurring pandemic over world. It was emerged in Wuhan, China, in the end of December 2019 and spreading across worldwide. As the coronavirus is spreading easily through direct contact with infected people droplets, inhalation, and also air droplets, it hit up a huge amount of population even reported with death. Still, with small amounts of asymptomatic transmission between people it spreads throughout the globe. People need special care to protect from the transmission of disease. However, there are no drugs so far that shows efficacy; there is an immediate need for the development of vaccines. In order to decrease the COVID-19 cases, organizations rapidly involve in the preparation of vaccine and many vaccines have been developed by various countries. The governments took safety measures to control the spread of virus and also to minimize morbidity and mortality rate to least possible.

CONCLUSION

The purpose of this review article is to increase our understanding of COVID-19 and facilitate the people to take a move in facing challenges of the world.

摘要

背景

一种新型冠状病毒被正式命名为严重急性呼吸综合征冠状病毒2(SARS-CoV-2),它导致了2019冠状病毒病(COVID-19)。与禽流感、中东呼吸综合征和严重急性呼吸综合征(SARS)等其他传染病相比,它是目前全球流行的最新大流行病。

正文

2019冠状病毒病(COVID-19)目前正在全球范围内大流行。它于2019年12月底在中国武汉出现,并在全球传播。由于冠状病毒很容易通过直接接触感染者的飞沫、吸入以及空气飞沫传播,它感染了大量人群,甚至有死亡报告。尽管如此,人与人之间仍有少量无症状传播,它在全球范围内传播。人们需要特别护理以防止疾病传播。然而,目前尚无显示出疗效的药物;迫切需要研发疫苗。为了减少COVID-19病例,各组织迅速参与疫苗的制备,各国已经研发出了许多疫苗。政府采取安全措施来控制病毒传播,并将发病率和死亡率降至最低。

结论

这篇综述文章的目的是增进我们对COVID-19的了解,并促使人们采取行动应对全球挑战。

相似文献

1
SARS-CoV-2 infection: a global outbreak and its implication on public health.
Bull Natl Res Cent. 2021;45(1):139. doi: 10.1186/s42269-021-00599-7. Epub 2021 Aug 3.
2
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
J Infect Public Health. 2020 Nov;13(11):1601-1610. doi: 10.1016/j.jiph.2020.07.011. Epub 2020 Aug 4.
3
The novel zoonotic COVID-19 pandemic: An expected global health concern.
J Infect Dev Ctries. 2020 Mar 31;14(3):254-264. doi: 10.3855/jidc.12671.
4
Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS.
Przegl Epidemiol. 2020;74(2):276-289. doi: 10.32394/pe.74.21.
5
Modeling and tracking Covid-19 cases using Big Data analytics on HPCC system platformm.
J Big Data. 2021;8(1):33. doi: 10.1186/s40537-021-00423-z. Epub 2021 Feb 15.
6
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
8
Third Wave of the COVID-19 Pandemic: Prominence of Initial Public Health Interference.
Infect Disord Drug Targets. 2022;22(4):e080222200919. doi: 10.2174/1871526522666220208115101.
9
Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions.
Saudi J Biol Sci. 2022 Apr;29(4):1981-1997. doi: 10.1016/j.sjbs.2021.12.020. Epub 2021 Dec 13.

引用本文的文献

2
Structural, genomic information and computational analysis of emerging coronavirus (SARS-CoV-2).
Bull Natl Res Cent. 2022;46(1):170. doi: 10.1186/s42269-022-00861-6. Epub 2022 Jun 15.

本文引用的文献

1
On the origin and continuing evolution of SARS-CoV-2.
Natl Sci Rev. 2020 Jun;7(6):1012-1023. doi: 10.1093/nsr/nwaa036. Epub 2020 Mar 3.
2
3
Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees.
Clin Infect Dis. 2022 Jan 29;74(2):366-368. doi: 10.1093/cid/ciab411.
4
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.
Nature. 2021 May;593(7857):130-135. doi: 10.1038/s41586-021-03398-2. Epub 2021 Mar 8.
5
COVID-19 vaccines: rapid development, implications, challenges and future prospects.
Hum Cell. 2021 May;34(3):711-733. doi: 10.1007/s13577-021-00512-4. Epub 2021 Mar 7.
6
SARS-CoV-2 spike D614G change enhances replication and transmission.
Nature. 2021 Apr;592(7852):122-127. doi: 10.1038/s41586-021-03361-1. Epub 2021 Feb 26.
7
Molecular biology of coronaviruses: current knowledge.
Heliyon. 2020 Aug;6(8):e04743. doi: 10.1016/j.heliyon.2020.e04743. Epub 2020 Aug 17.
8
COVID-19: Transmission, prevention, and potential therapeutic opportunities.
Clin Chim Acta. 2020 Sep;508:254-266. doi: 10.1016/j.cca.2020.05.044. Epub 2020 May 29.
9
Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?
PLoS Pathog. 2020 May 14;16(5):e1008421. doi: 10.1371/journal.ppat.1008421. eCollection 2020 May.
10
COVID-19: animals, veterinary and zoonotic links.
Vet Q. 2020 Dec;40(1):169-182. doi: 10.1080/01652176.2020.1766725.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验